Sorted By:

Relevance


PhRMA Statement on FDA Biomedical Innovation Report

PhRMA  |  Press Release

  “Importantly, many of the themes discussed in the report are consistent with the provisions in the recently negotiated PDUFA-V technical agreement.  
https://www.phrma.org/press-release/phrma-statement-on-fda-biomedical-innovation-report

New Report: Alzheimer’s Research “Setbacks” Critical for Breakthroughs of Tomorrow

PhRMA  |  Press Release

To showcase the science driving Alzheimer’s research, PhRMA will host a live webcast on July 15 at 1:30 pm (EDT) to discuss the report’s findings.
https://www.phrma.org/press-release/new-report-alzheimer-s-research-setbacks-critical-for-breakthroughs-of-tomorrow

PhRMA Comments on the 2010 Special 301 Report

PhRMA  |  Press Release

Industry-wide research and investment reached a record $65.2 billion in 2008.
https://www.phrma.org/press-release/phrma-comments-on-the-2010-special-301-report

PhRMA Statement on Senate Health Care Reform Bill

PhRMA  |  Press Release

“What’s critical now is that we remain focused on the important goal of helping pass a comprehensive health care reform bill that can get to the President’s desk this year.
https://www.phrma.org/press-release/phrma-statement-on-senate-health-care-reform-bill

Medicare Monday: What is in the 2016 Medicare Trustees report

PhRMA  |  Blog Post

While this year’s report pushed off triggering IPAB for another year, it remains a serious threat to seniors and could come between patients and their health care providers.
http://catalyst.phrma.org/medicare-monday-what-is-in-the-2016-medicare-trustees-report

New report highlights more than 250 vaccines in development

PhRMA  |  Blog Post

View the full report here.
http://catalyst.phrma.org/catalyst-dev/new-report-highlights-more-than-250-vaccines-in-development-0

Medicines in Development for Infectious Diseases 2013 Report

PhRMA  |  Report

Throughout history, infectious diseases have taken a devastating toll on the lives and well-being of people around the world. Caused when pathogens such as bacteria or viruses enter a body and multiply, infectious diseases were the leading cause of death in the United States until the 1920s. Toda...
https://www.phrma.org

PhRMA Reports 836 Medicines and Vaccines in Development to Treat Cancer

PhRMA  |  Press Release

View the full reportView the medicine list   About The Pharmaceutical Research and Manufacturers of America (PhRMA) The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives.
https://www.phrma.org/press-release/phrma-reports-836-medicines-and-vaccines-in-development-to-treat-cancer

New report highlights more than 250 vaccines in development

PhRMA  |  Blog Post

View the full report here.
http://catalyst.phrma.org/new-report-highlights-more-than-250-vaccines-in-development

PhRMA Statement on Health Care Reform

PhRMA  |  Press Release

Industry-wide research and investment reached a record $65.2 billion in 2008.
https://www.phrma.org/press-release/phrma-statement-on-health-care-reform

Moran Company Study on Hospital Markups of Medicines

PhRMA  |  Report

This report by the Moran Company identifies this hidden threat to affordability that is a driver of higher cost sharing and premiums for patients across the country.
https://www.phrma.org/report/moran-company-study-on-hospital-markups-of-medicines

340B 101

PhRMA  |  Report

Download the deck to learn more about the 340B program....
https://www.phrma.org/report/340b-101

What They Are Saying: Stakeholders Raise Concerns about Patent Litigation Reform

PhRMA  |  Blog Post

.” – Heather Wilson, President, South Dakota School of Mines & Technology in Roll Call April 13, 2015 “The pending patent reform bill, called the “Innovation Act,” is targeted at frivolous cases, right?
http://catalyst.phrma.org/what-they-are-saying-stakeholders-raise-concerns-about-patent-litigation-reform

PhRMA Statement on Health Care Reform Ad

PhRMA  |  Press Release

Industry-wide research and investment reached a record $65.3 billion in 2009.
https://www.phrma.org/press-release/phrma-statement-on-health-care-reform-ad

PhRMA Statement on Patent Reform Agreement

PhRMA  |  Press Release

Industry-wide research and investment reached a record $65.2 billion in 2008.
https://www.phrma.org/press-release/phrma-statement-on-patent-reform-agreement

PhRMA Statement on Special 301 Report

PhRMA  |  Press Release

The 2012 report particularly notes that USTR has sought to reduce market access barriers that U.S. pharmaceutical and medical device companies face in many countries, and to facilitate both affordable health care today and the innovation that assures improved health care tomorrow.
https://www.phrma.org/press-release/phrma-statement-on-special-301-report

Charles River Associates Releases Updated HTA Comparison Report

PhRMA  |  Press Release

The report’s findings underscore the importance of patient-centered, evidence-informed and holistic approaches to effectively and efficiently increase equitable access to quality healthcare services. 
https://www.phrma.org/press-release/charles-river-associates-releases-updated-hta-comparison-report

PhRMA Statement on 2013 Special 301 Report

PhRMA  |  Press Release

WASHINGTON, D.C. (May 1, 2013) – Pharmaceutical Research and Manufacturers of America (PhRMA) International Vice President Jay Taylor issued the following statement today: Maintaining global incentives for research and development into new medicines is essential for contin...
https://www.phrma.org/press-release/phrma-statement-on-2013-special-301-report

Statement Regarding GAO Report on Drug Prices

PhRMA  |  Press Release

Industry-wide research and investment reached a record $65.3 billion in 2009.
https://www.phrma.org/press-release/statement-regarding-gao-report-on-drug-prices

New Report: Forecasts for Specialty Medicines Have Been Overstated

PhRMA  |  Blog Post

Given the findings of the Milliman report, it seems clear that PBM forecasts for selected subsets of prescription medicines should be interpreted with caution.
http://catalyst.phrma.org/new-report-forecasts-for-specialty-medicines-have-been-overstated

PhRMA Comments to the 2017 National Trade Estimate Report

PhRMA  |  Policy Paper

The attached submission, presented to the Trade Policy Staff Committee of the Executive Office of the President on behalf of PhRMA and its member companies, identifies significant barriers to the export of goods, services and overseas direct investment for for inclusion in the 2017 National Trade Estimate Report (NTE). 
https://www.phrma.org/policy-paper/phrma-comments-to-the-2017-nte-report

RA Report: Recognizing the Value of Innovation in the Treatment of Rheumatoid Arthritis

PhRMA  |  Report

In recent years, we have seen significant progress in our ability to diagnose and manage chronic diseases. Among autoimmune conditions such as rheumatoid arthritis (RA), lupus, and multiple sclerosis, treatment advances have played a major role in slowing disease progression, improving quality of...
https://www.phrma.org/report/ra-report-recognizing-the-value-of-innovation-in-the-treatment-of-rheumatoid-arthritis

BMJ clinical trial report misleading

PhRMA  |  Blog Post

  For example, the authors assert that only 67% of the reviewed studies were “timely” reported according to FDAAA standards.
http://catalyst.phrma.org/bmj-clinical-trial-report-misleading

Medicines in Development for Skin Diseases 2011 Report

PhRMA  |  Report

America’s biopharmaceutical research companies are currently developing 277 medicines to help the more than 100 million Americans—one-third of the U.S. population—afflicted with at least one skin disease, ranging from acne to melanoma. All of the medicines are either in clinical trials or awaitin...
https://www.phrma.org/report/medicines-in-development-for-skin-diseases

Comprehensive Health Reform: A Must Pass This Year

PhRMA  |  Press Release

Industry-wide research and investment reached a record $58.8 billion in 2007.
https://www.phrma.org/press-release/comprehensive-health-reform-a-must-pass-this-year

You have reviewed the first 100 results out of 1032. Each page contains 25 results. You're on page 4.

prev 1 2 3 4 5 6 next